ResMed Inc. (RSMDF)
OTCMKTS · Delayed Price · Currency is USD
16.63
0.00 (0.00%)
Aug 12, 2025, 8:00 PM EDT
ResMed Market Cap
ResMed has a market cap or net worth of $42.21 billion as of August 14, 2025. Its market cap has increased by 37.78% in one year.
Market Cap
42.21B
Enterprise Value
41.85B
Revenue
5.15B
Ranking
n/a
PE Ratio
30.13
Stock Price
$16.63
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 38.59M to 42.21B, an increase of 109,269.62%. That is a compound annual growth rate of 26.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 42.21B | 25.69% |
| Dec 31, 2024 | 33.58B | 32.73% |
| Dec 29, 2023 | 25.30B | -17.24% |
| Dec 30, 2022 | 30.57B | -19.72% |
| Dec 31, 2021 | 38.08B | 23.63% |
| Dec 31, 2020 | 30.80B | 38.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 560.80M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 360.45M |
| CytoDyn | 300.75M |